Oxygen Therapy Market Introduction and Overview
According to SPER Market Research, the Global Oxygen Therapy Market is estimated to reach USD 66.26 billion by 2032 with a CAGR of 6.03%.
The report includes an in-depth analysis of the Global Oxygen Therapy market, including market size and trends, product mix, distribution channels, and supplier analysis. Oxygen therapy is a medical intervention that provides a higher concentration of oxygen to those who have trouble breathing or have diseases that cause low oxygen levels in their blood. It entails the regulated delivery of supplemental oxygen using various delivery systems such as nasal cannulas, face masks, or ventilators.
- In November 2021, UNICEF teamed with the British government and Oxygen CoLab to develop a robust oxygen concentrator for use in resource-limited areas. This effort is now being carried out in order to tackle the coronavirus problem while also meeting the demand for oxygen in critical care settings.
- In July 2021, Belluscura (BELL) announced the signing of its first contract and third distribution agreement with a manufacturer of durable medical equipment for its X-PLO2RTM line of portable oxygen concentrators. Durable medical equipment (or "DME") is available online and at a number of stores across the country. While this is going on, the third distributor has already ordered the X-PLO2RTM portable oxygen concentrator, which should arrive in less than 90 days.
Market Opportunities and Challenges
The oxygen therapy market offers considerable opportunities as well as significant challenges. On the opportunity front, the rising prevalence of respiratory disorders such as COPD, asthma, and sleep apnea, along with an aging population, has resulted in an increase in demand for oxygen therapy equipment and services. Technological advancements have also resulted in the creation of more efficient and portable oxygen delivery devices that can meet the needs of a larger patient population.
However, this rising business faces a number of challenges. The cost of oxygen therapy equipment and subsequent maintenance might be too expensive for some patients, creating financial barriers to access. Because of the life-saving nature of oxygen therapy, regulatory compliance and quality assurance in manufacturing and distribution are critical, which can be a considerable barrier for enterprises in the field. Furthermore, the market is very competitive, with a slew of manufacturers and suppliers striving for market dominance, putting downward pressure on prices.
Market Competitive Landscape
The oxygen therapy industry is characterized by fierce competition among numerous big competitors as well as a plethora of smaller enterprises and suppliers. Well-known medical equipment manufacturers dominate the industry, including Philips Healthcare, Linde Group, Invacare Corporation, and ResMed, among others. These market leaders frequently offer a diverse selection of oxygen therapy goods and have a strong global presence, making them formidable competitors.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2032 |
| Base year considered | 2021 |
| Forecast period | 2022-2032 |
| Segments covered | By Product, By Portability, By Application, By End Use
|
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.
|
| Companies Covered | CAllied Healthcare Products, Inc., Andreas Fahl Medizintechnik-Vertriebs GmbH, Becton, Dickinson and Company, CAIRE, Chart Industries, Inc., DeVilbiss Healthcare Drägerwerk AG & Co. KGaA, Essex Industries, Inc., Fisher & Paykel Healthcare Corporation Limited, GCE Holding AB, GE Healthcare, Heinen + Löwenstein GmbH & Co. KG, HERSILL S.L., HUM - Gesellschaft für Homecare und Medizintechnik mbH, Inogen, Inc., Invacare Corporation, IUC Medical, Linde Healthcare, Medicap homecare GmbH, Medicop D.O.O., Messer Medical Austria GmbH, Philips Healthcare, Philips Respironics, Inc., ResMedDrägerwerk AG & Co. KGaALinde, Respan Products Inc., Smiths Medical, Taiyo Nippon Sanso Corporation, Tecno-Gaz IndustriesTeleflex Incorporated, Weinmann Emergency Medical Technology GmbH + Co. KG.
|
COVID-19 Impact on Global Oxygen Therapy Market
The COVID-19 pandemic had a significant impact on the medical device industry as a result of lockdown requirements and supply chain management concerns. However, because oxygen therapy was employed as the first line of treatment for critically ill patients infected with coronaviruses, oxygen therapy equipment was in great demand throughout the crisis. As a result of a major global ventilator shortage, demand for oxygen concentrators increased dramatically. In order to overcome this scarcity, biomedical engineers and scientists have built temporary systems that mimic the key functions of ventilators by leveraging existing equipment such as oxygen concentrators, PAP machines, anaesthetic machines, and manual resuscitators.
Key Target Audience:
- Healthcare Providers
- Patients
- Medical Equipment Manufacturers and Suppliers
- Pharmaceutical Companies
- Investors and Stakeholders
- Others
Our in-depth analysis of the Oxygen Therapy Market includes the following segments:
|
By Product:
|
Oxygen Delivery Devices
|
|
By Portability:
|
Stationary Devices
Portable Devices
|
|
By Application:
|
Chronic Obstructive Pulmonary Disease (COPD)
Asthma
Cystic Fibrosis
Respiratory Distress Syndrome
Pneumonia
|
|
By End User:
|
Home Healthcare
Non-Home Healthcare
Ambulatory Surgical Centers & Physician Offices
|
Key Topics Covered in the Report:
- Global Oxygen Therapy Market Size (FY’2022-FY’2032)
- Overview of Global Oxygen Therapy Market
- Segmentation of Global Oxygen Therapy Market By Product (Oxygen Source Equipment, Oxygen Delivery Devices, Others)
- Segmentation of Global Oxygen Therapy Market By Portability (Stationary Devices and Portable Devices)
- Segmentation of Global Oxygen Therapy Market By Application (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Cystic Fibrosis, Respiratory Distress Syndrome, Pneumonia, Other Diseases.)
- Segmentation of Global Oxygen Therapy Market By End User (Home Healthcare, Non-Home Healthcare, Ambulatory Surgical Centers & Physician Offices.)
- Statistical Snap of Global Oxygen Therapy Market
- Expansion Analysis of Global Oxygen Therapy Market
- Problems and Obstacles in Global Oxygen Therapy Market
- Competitive Landscape in the Global Oxygen Therapy Market
- Impact of COVID-19 and Demonetization on Global Oxygen Therapy Market
- Details on Current Investment in Global Oxygen Therapy Market
- Competitive Analysis of Global Oxygen Therapy Market
- Prominent Players in the Global Oxygen Therapy Market
- SWOT Analysis of Global Oxygen Therapy Market
- Global Oxygen Therapy Market Future Outlook and Projections (FY’2022-FY’2032)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Oxygen Therapy Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Oxygen Therapy Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Oxygen Therapy Market
7. Global Oxygen Therapy Market, By Product (USD Million)
7.1. Global Oxygen Therapy Market Value Share and Forecast, By Product, 2022-2032
7.2. Oxygen Source Equipment
7.3. Oxygen Delivery Devices
7.4. Others
8. Global Oxygen Therapy Market, By Portability (USD Million)
8.1. Global Oxygen Therapy Market Value Share and Forecast, By Portability, 2022-2032
8.2. Stationary Devices
8.3. Portable Devices
9. Global Oxygen Therapy Market, By Application (USD Million)
9.1. Global Oxygen Therapy Market Value Share and Forecast, By Application, 2022-2032
9.2. Chronic Obstructive Pulmonary Disease (COPD)
9.3. Asthma
9.4. Cystic Fibrosis
9.5. Respiratory Distress Syndrome
9.6. Pneumonia
9.7. Others
10. Global Oxygen Therapy Market, By End User (USD Million)
10.1. Global Oxygen Therapy Market Value Share and Forecast, By End User, 2023-2032
10.2. Home Healthcare
10.3. Non-Home Healthcare
10.4. Ambulatory Surgical Centers & Physician Offices
11. Global Oxygen Therapy Market Forecast, 2019-2032 (USD Million)
11.1. Global Oxygen Therapy Market Size and Market Share
12. Global Oxygen Therapy Market, By Product, 2019-2032 (USD Million)
12.1. Global Oxygen Therapy Market Size and Market Share By Product (2019-2026)
12.2. Global Oxygen Therapy Market Size and Market Share By Product (2027-2032)
13. Global Oxygen Therapy Market, By Portability, 2019-2032 (USD Million)
13.1. Global Oxygen Therapy Market Size and Market Share By Portability (2019-2026)
13.2. Global Oxygen Therapy Market Size and Market Share By Portability (2027-2032)
14. Global Oxygen Therapy Market, By Application, 2019-2032 (USD Million)
14.1. Global Oxygen Therapy Market Size and Market Share By Application (2019-2026)
14.2. Global Oxygen Therapy Market Size and Market Share By Application (2027-2032)
15. Global Oxygen Therapy Market, By End User, 2019-2032 (USD Million)
15.1. Global Oxygen Therapy Market Size and Market Share By End User (2019-2026)
15.2. Global Oxygen Therapy Market Size and Market Share By End User (2027-2032)
16. Global Oxygen Therapy Market, By Region, 2019-2032 (USD Million)
16.1. Global Oxygen Therapy Market Size and Market Share By Region (2019-2026)
16.2. Global Oxygen Therapy Market Size and Market Share By Region (2027-2032)
16.3. Asia-Pacific
16.3.1. Australia
16.3.2. China
16.3.3. India
16.3.4. Japan
16.3.5. South Korea
16.3.6. Rest of Asia-Pacific
16.4. Europe
16.4.1. France
16.4.2. Germany
16.4.3. Italy
16.4.4. Spain
16.4.5. United Kingdom
16.4.6. Rest of Europe
16.5. Middle East and Africa
16.5.1. Kingdom of Saudi Arabia
16.5.2. United Arab Emirates
16.5.3. Rest of Middle East & Africa
16.6. North America
16.6.1. Canada
16.6.2. Mexico
16.6.3. United States
16.7. Latin America
16.7.1. Argentina
16.7.2. Brazil
16.7.3. Rest of Latin America
17. Company Profile
17.1. Allied Healthcare Products, Inc.
17.1.1. Company details
17.1.2. Financial outlook
17.1.3. Product summary
17.1.4. Recent developments
17.2. Andreas Fahl Medizintechnik-Vertriebs GmbH
17.2.1. Company details
17.2.2. Financial outlook
17.2.3. Product summary
17.2.4. Recent developments
17.3. Becton, Dickinson and Company
17.3.1. Company details
17.3.2. Financial outlook
17.3.3. Product summary
17.3.4. Recent developments
17.4. CAIRE
17.4.1. Company details
17.4.2. Financial outlook
17.4.3. Product summary
17.4.4. Recent developments
17.5. Chart Industries, Inc.
17.5.1. Company details
17.5.2. Financial outlook
17.5.3. Product summary
17.5.4. Recent developments
17.6. DeVilbiss Healthcare
17.6.1. Company details
17.6.2. Financial outlook
17.6.3. Product summary
17.6.4. Recent development
17.7. Drägerwerk AG & Co. KGaA
17.7.1. Company details
17.7.2. Financial outlook
17.7.3. Product summary
17.7.4. Recent development
17.8. Essex Industries, Inc.
17.8.1. Company details
17.8.2. Financial outlook
17.8.3. Product summary
17.8.4. Recent development
17.9. Fisher & Paykel Healthcare Corporation Limited
17.9.1. Company details
17.9.2. Financial outlook
17.9.3. Product summary
17.9.4. Recent development
17.10. GCE Holding AB
17.10.1. Company details
17.10.2. Financial outlook
17.10.3. Product summary
17.10.4. Recent development
17.11. GE Healthcare
17.11.1. Company details
17.11.2. Financial outlook
17.11.3. Product summary
17.11.4. Recent development
17.12. Heinen + Löwenstein GmbH & Co. KG
17.12.1. Company details
17.12.2. Financial outlook
17.12.3. Product summary
17.12.4. Recent development
17.13. HERSILL S.L.
17.13.1. Company details
17.13.2. Financial outlook
17.13.3. Product summary
17.13.4. Recent development
17.14. HUM - Gesellschaft für Homecare und Medizintechnik mbH
17.14.1. Company details
17.14.2. Financial outlook
17.14.3. Product summary
17.14.4. Recent development
17.15. Inogen, Inc.
17.15.1. Company details
17.15.2. Financial outlook
17.15.3. Product summary
17.15.4. Recent development
17.16. Invacare Corporation
17.16.1. Company details
17.16.2. Financial outlook
17.16.3. Product summary
17.16.4. Recent development
17.17. IUC Medical
17.17.1. Company details
17.17.2. Financial outlook
17.17.3. Product summary
17.17.4. Recent development
17.18. Linde Healthcare
17.18.1. Company details
17.18.2. Financial outlook
17.18.3. Product summary
17.18.4. Recent development
17.19. Medicap homecare GmbH
17.19.1. Company details
17.19.2. Financial outlook
17.19.3. Product summary
17.19.4. Recent development
17.20. Medicop D.O.O.
17.20.1. Company details
17.20.2. Financial outlook
17.20.3. Product summary
17.20.4. Recent development
17.21. Messer Medical Austria GmbH
17.21.1. Company details
17.21.2. Financial outlook
17.21.3. Product summary
17.21.4. Recent development
17.22. Philips Healthcare
17.22.1. Company details
17.22.2. Financial outlook
17.22.3. Product summary
17.22.4. Recent development
17.23. Philips Respironics, Inc.
17.23.1. Company details
17.23.2. Financial outlook
17.23.3. Product summary
17.23.4. Recent development
17.24. ResMedDrägerwerk AG & Co. KGaALinde
17.24.1. Company details
17.24.2. Financial outlook
17.24.3. Product summary
17.24.4. Recent development
17.25. Respan Products Inc.
17.25.1. Company details
17.25.2. Financial outlook
17.25.3. Product summary
17.25.4. Recent development
17.26. Smiths Medical
17.26.1. Company details
17.26.2. Financial outlook
17.26.3. Product summary
17.26.4. Recent development
17.27. Taiyo Nippon Sanso Corporation
17.27.1. Company details
17.27.2. Financial outlook
17.27.3. Product summary
17.27.4. Recent development
17.28. Tecno-Gaz Industries
17.28.1. Company details
17.28.2. Financial outlook
17.28.3. Product summary
17.28.4. Recent development
17.29. Teleflex Incorporated
17.29.1. Company details
17.29.2. Financial outlook
17.29.3. Product summary
17.29.4. Recent development
17.30. Others
18. List of Abbreviations
19. Reference Links
20. Conclusion
21. Research Scope